REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Liopharm Sp. z o.o. (Poland)

Main Activities: All Other Food Manufacturing
Secondary Activities: Dog and Cat Food Manufacturing | Pharmaceutical and Medicine Manufacturing | Toilet Preparation Manufacturing | General Line Grocery Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Other Miscellaneous Store Retailers | Outpatient Care Centers
Full name: Liopharm Sp. z o.o. Profile Updated: September 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Genactiv uses a colostrum drying method involving freezing and liofilization processes to maintain the bioactive levels of their products. Genactiv's products are based on two active ingredients: Colostrum and Milk clay. The company's main business activities include the production and sale of colostrum-based supplements and dermokosmetics.

Headquarters
Ul. Polna 13/3
Dabrowka; Wielkopolskie; Postal Code: 62-070

Contact Details: Purchase the Liopharm Sp. z o.o. report to view the information.

Website: http://www.genactiv.pl

Basic Information
Total Employees:
Purchase the Liopharm Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Liopharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Liopharm Sp. z o.o. report to view the information.
Incorporation Date:
December 12, 2005
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Liopharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
47.23%▲
Total operating revenue
43.76%▲
Operating profit (EBIT)
163.68%▲
EBITDA
159.98%▲
Net Profit (Loss) for the Period
212.32%▲
Total assets
68.34%▲
Total equity
108.69%▲
Operating Profit Margin (ROS)
9.79%▲
Net Profit Margin
10.15%▲
Return on Equity (ROE)
14.03%▲
Debt to Equity Ratio
1.61%▲
Quick Ratio
0.32%▲
Cash Ratio
0.06%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo